ClinicalTrials.gov
ClinicalTrials.gov Menu

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01571661
Recruitment Status : Completed
First Posted : April 5, 2012
Last Update Posted : April 5, 2012
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline